Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR659 - MicroRNA-135b overexpression effect on prostate cancer cell line: time course
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR659 - U2OS osteosarcoma cell line response to strigolactone analogs ST362 and MEB55: 6 hours
MIR659 - ErbB4 isoforms CYT-1 and CYT-2 overexpression effect on MCF10A mammary epithelial cells
MIR659 - Glioblastoma cells response to Focal Adhesion Kinase Inhibitor Y15 and Temozolomide
MIR659 - H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast cancer cells: dose response
MIR659 - VprBP depletion effect on prostate cancer cell line
MIR659 - Proteasome inhibitor Bortezomib effect on MCF7 breast cancer cells
MIR659 - DEK oncogene deficiency effect in U937 leukemic monocyte lymphoma cells
MIR659 - Pancreatic cancer-stellate cell organotypic cultures
MIR659 - Mutant HLA-F-adjacent transcript 10 overexpression effect on HCT116 colon cancer cell line
MIR659 - Short-term fasting effect on skeletal muscle: time course
GEO DataSets Gene Chromosome neighbors
MIR659 - Interstitial fluid flow effect on noninvasive and invasive ERBB2-positive breast cancer cells
MIR659 - miR-542-3p overexpression effect on TP53 wild-type osteosarcoma cell line
MIR659 - BET inhibitor I-BET726 effect on MYCN-amplified neuroblastoma cell line CHP-212: dose response
MIR659 - Histone demethylase KDM3A-deficiency effect on estrogen-stimulated breast cancer cells in vitro
MIR659 - H3K79 histone methyl transferase DOT1L inhibitor Compound 55 effect on breast cancer cells: dose response
MIR659 - Bipolar disorder and response to lithium: blood
MIR659 - BET inhibitor I-BET726 effect on non-MYCN-amplified neuroblastoma cell line SK-N-SH: dose response
MIR659 - Dasatinib-resistant and dasatinib-sensitive pancreatic cancer cell lines
MIR659 - Metastatic breast cancer and sepsis: monocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on